Robert A. Michael - 28 Feb 2024 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
PRES & CHIEF OPERATING OFFICER
Signature
T.O. Odutayo, attorney-in-fact for Robert A. Michael
Issuer symbol
ABBV
Transactions as of
28 Feb 2024
Transactions value $
-$18,890,783
Form type
4
Filing time
01 Mar 2024, 17:50:42 UTC
Previous filing
20 Feb 2024
Next filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Tax liability -$6.74M -37.6K -20.5% $178.99 146K 28 Feb 2024 Direct
transaction ABBV Common Stock, $0.01 par value Options Exercise $701K +11.4K +7.82% $61.36* 157K 29 Feb 2024 Direct
transaction ABBV Common Stock, $0.01 par value Options Exercise $556K +10.1K +6.44% $54.86* 168K 29 Feb 2024 Direct
transaction ABBV Common Stock, $0.01 par value Sale -$3.8M -21.6K -12.87% $176.44 146K 29 Feb 2024 Direct F1
transaction ABBV Common Stock, $0.01 par value Sale -$8.35M -47.3K -32.42% $176.46 98.6K 29 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABBV Option (Right to Buy) Options Exercise -$701K -11.4K -100% $61.36* 0 29 Feb 2024 Common Stock 11.4K $61.36 Direct F3
transaction ABBV Option (Right to Buy) Options Exercise -$556K -10.1K -100% $54.86* 0 29 Feb 2024 Common Stock 10.1K $54.86 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.39 to $176.57, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.42 to $176.60, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.